{"entity":{"id":"1986","kind":"year","name":"1986 in oncology","aka":["1986"],"tldr":"Everything OnCo dates to 1986: 16 entries, 8 landmarks, 4 journals founded, 1 approval and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"16 dated entries in OnCo fall in 1986: 8 landmarks, 4 journals founded, 1 approval, 1 company founded, 1 paper and 1 technology.\n\nOf those, 16 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["1985","1987"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":1986,"events":[{"group":"approval","date":"1986","precision":"year","title":"Interferon alfa-2a/2b approved in US","note":"Hairy cell leukaemia","from":"interferon-alfa","refs":[]},{"group":"company","date":"1986","precision":"year","title":"ARCH Venture Partners founded","note":"Chicago, IL","from":"arch-venture-partners","refs":[]},{"group":"history","date":"1986","precision":"year","title":"EMA-CO reported as a regimen for high-risk disease","note":"High-risk gestational trophoblastic neoplasia (FIGO score 7 or more, including ultra-high-risk)","from":"high-risk-gtn","refs":["etoposide","methotrexate","dactinomycin","cyclophosphamide"]},{"group":"history","date":"1986","precision":"year","title":"Frierson and colleagues define sinonasal undifferentiated carcinoma","note":"Sinonasal undifferentiated carcinoma (SNUC) and SWI/SNF-deficient sinonasal carcinoma","from":"sinonasal-undifferentiated-carcinoma","refs":[]},{"group":"history","date":"1986","precision":"year","title":"Frierson describes sinonasal undifferentiated carcinoma","note":"Nasal cavity and paranasal sinus cancers (including esthesioneuroblastoma)","from":"sinonasal","refs":[]},{"group":"history","date":"1986","precision":"year","title":"ISSVD recognises vulvar intraepithelial neoplasia as the precursor lesion","note":"HPV-associated vulvar squamous cell carcinoma","from":"hpv-associated-vulvar-cancer","refs":["hpv-p16"]},{"group":"history","date":"1986","precision":"year","title":"PSA test approved for monitoring; screening spreads in the 1990s","note":"Prostate cancer","from":"prostate","refs":["psa"]},{"group":"history","date":"1986","precision":"year","title":"Randomised proof that adjuvant chemotherapy cures (Link, NEJM; MIOS)","note":"Osteosarcoma","from":"osteosarcoma","refs":[]},{"group":"history","date":"1986","precision":"year","title":"RB1 cloned (Friend, Weinberg, Dryja)","note":"Retinoblastoma. The first tumour-suppressor gene identified.","from":"retinoblastoma","refs":["tp53"]},{"group":"history","date":"1986","precision":"year","title":"The circumferential resection margin explains local recurrence","note":"Colorectal cancer. Quirke sliced 52 rectal specimens transversely: 14 had tumour at the lateral margin and 12 of those recurred locally, which redefined recurrence as a problem of...","from":"colorectal","refs":["circumferential-resection-margin"]},{"group":"journal","date":"1986","precision":"year","title":"Journal of cancer education founded","note":"Springer Nature","from":"journal-of-cancer-education","refs":[]},{"group":"journal","date":"1986","precision":"year","title":"Pediatric hematology and oncology founded","note":"Taylor & Francis (Informa UK)","from":"pediatric-hematology-and-oncology","refs":[]},{"group":"journal","date":"1986","precision":"year","title":"Strahlentherapie und Onkologie founded","note":"Springer Nature (Springer Medizin)","from":"strahlentherapie-und-onkologie","refs":[]},{"group":"journal","date":"1986","precision":"year","title":"The International journal of biological markers founded","note":"SAGE Publishing","from":"international-journal-of-biological-markers","refs":[]},{"group":"paper","date":"1986","precision":"year","title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","note":"Dvorak HF. New England Journal of Medicine.","from":"paper-dvorak-n-engl-j-med","refs":[]},{"group":"technology","date":"1986","precision":"year","title":"Cancer pain management","note":"First use in humans or first approval, as the technology record states it.","from":"pain-management","refs":[]}]},"route":"/years/1986/","neighbours":{"year":[{"id":"1985","kind":"year","name":"1985 in oncology","route":"/years/1985/"},{"id":"1987","kind":"year","name":"1987 in oncology","route":"/years/1987/"}]}}